Table 2 Distribution of individual genotypes among CT (+) and CT (-) tumors
Polymorphism | Genotype | CT (+) Tumors, n (%) | CT (-) Tumors, n (%) | χ2 | P* |
|---|---|---|---|---|---|
MTHFR 677 C>T (rs1801133) | CC | 13 (62%) | 7 (24%) | 7.30 | 0.03 |
CT | 5 (24%) | 15 (52%) | |||
TT | 3 (14%) | 7 (24%) | |||
MTHFR 1298 A>C (rs1801131) | AA | 13 (62%) | 14 (48%) | 0.91 | 0.63 |
AC | 7 (33%) | 13 (45%) | |||
CC | 1 (5%) | 2 (7%) | |||
MTR 2756 A>G (rs1805087) | AA | 14 (67%) | 22 (76%) | 0.51 | 0.53** |
AG | 7 (33%) | 7 (24%) | |||
GG | 0 (0%) | 0 (0%) | |||
MTRR 66 A>G (rs1801394) | AA | 4 (19%) | 9 (31%) | 0.92 | 0.63 |
AG | 10 (48%) | 12 (41%) | |||
GG | 7 (33%) | 8 (28%) | |||
RFC 80Â G>A (rs1051266) | GG | 6 (29%) | 12 (41%) | 1.90 | 0.39 |
GA | 9 (43%) | 13 (45%) | |||
| Â | AA | 6 (29%) | 4 (14%) | Â | Â |